pmid,title,journal,year,drug,disease
38309091,Combination therapy of high-dose intravenous anakinra and baricitinib in patients with critical COVID-19: Promising results from retrospective observational study.,International immunopharmacology,2024,Baricitinib,Myocardial Infarction
37013725,Adverse events in patients treated with Jak-inhibitors for alopecia areata: A systematic review.,Journal of the European Academy of Dermatology and Venereology : JEADV,2023,Baricitinib,Myocardial Infarction
36828654,Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial.,BMJ open,2023,Baricitinib,Myocardial Infarction
36763878,Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.,The British journal of dermatology,2023,Baricitinib,Myocardial Infarction
35087406,Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews.,Frontiers in pharmacology,2021,Baricitinib,Myocardial Infarction
34299092,"Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells.",International journal of molecular sciences,2021,Baricitinib,Myocardial Infarction
31635416,Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells.,Cells,2019,Baricitinib,Myocardial Infarction
30663869,Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis.,"Arthritis & rheumatology (Hoboken, N.J.)",2019,Baricitinib,Myocardial Infarction
